This announcement is a separate document:
关于河南羚锐制药股份有限公司2021年限制性股票激励计划第三期解锁条件成就及回购注销部分限制性股票之专项法律意见书
Special Legal Opinion on the Achievement of Unlocking Conditions and Repurchase and Cancellation of Restricted Stocks of the Third Restricted Stock Incentive Plan of Henan Lingrui Pharmaceutical Co., Ltd. in 2021
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.